vaccine booster

AMA Update 269: RSV vaccines, measles outbreaks & cardiovascular risks from long COVID with Andrea Garcia, JD, MPH

8 de marzo de 2023 casimedicos AMA Update 00:10:35 0 Comments

AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, shares new study findings on increased risk of severe health complications linked to patients with long COVID, including: arrhythmias, stroke, heart failure, coronary artery disease, COPD and pulmonary embolisms. Also discussing growing measles outbreaks. Measles are extremely contagious, can cause life-threatening illness, and are an immediately notifiable disease. Physicians should promptly report cases to state health departments to notify the CDC within 24 hours via the National Notifiable Disease Surveillance System. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 251: Bivalent vaccine effectiveness, COVID booster schedule and Evusheld update with Sandra Fryhofer, MD

31 de enero de 2023 casimedicos AMA Update 00:15:02 0 Comments

AMA Board Chair Sandra Fryhofer, MD, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup, recaps the latest news from the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting. Topics include the vote on “harmonizing” strain composition for both COVID-19 primary vaccines and booster shots, as well as an update about the preliminary stroke risk signal for seniors who received a Pfizer booster. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 91: Andrea Garcia, JD, MPH, discusses EUA requests for boosters and children ages 5-11

13 de octubre de 2021 casimedicos AMA Update 00:13:46 0 Comments

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering COVID-19 vaccine emergency use authorization (EUA) requests from Pfizer for children ages 5-11, as well as movement on boosters for Johnson & Johnson and Moderna vaccine recipients.

Read More